A detailed history of Ifp Advisors, Inc transactions in Baxter International Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 6,235 shares of BAX stock, worth $207,064. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,235
Previous 8,879 29.78%
Holding current value
$207,064
Previous $379,000 45.12%
% of portfolio
0.01%
Previous 0.02%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$32.87 - $43.55 $86,908 - $115,146
-2,644 Reduced 29.78%
6,235 $208,000
Q1 2024

Jul 30, 2024

SELL
$37.88 - $43.77 $303 - $350
-8 Reduced 0.09%
8,879 $379,000
Q4 2023

Jan 09, 2024

SELL
$31.71 - $38.95 $56,316 - $69,175
-1,776 Reduced 16.66%
8,887 $343,000
Q3 2023

Oct 12, 2023

SELL
$37.32 - $49.29 $26,198 - $34,601
-702 Reduced 6.18%
10,663 $402,000
Q2 2023

Aug 04, 2023

BUY
$39.98 - $47.68 $154,002 - $183,663
3,852 Added 51.27%
11,365 $517,000
Q1 2023

Apr 18, 2023

SELL
$37.58 - $52.57 $45,622 - $63,819
-1,214 Reduced 13.91%
7,513 $304,000
Q4 2022

Feb 07, 2023

SELL
$49.7 - $57.71 $155,362 - $180,401
-3,126 Reduced 26.37%
8,727 $653,000
Q3 2022

Nov 08, 2022

BUY
$53.86 - $66.8 $38,725 - $48,029
719 Added 6.46%
11,853 $889,000
Q2 2022

Sep 06, 2022

BUY
$63.83 - $80.0 $710,427 - $890,400
11,130 Added 278250.0%
11,134 $835,000
Q2 2022

Aug 12, 2022

SELL
$63.83 - $80.0 $710,427 - $890,400
-11,130 Reduced 99.96%
4 $1,000
Q1 2022

Sep 06, 2022

BUY
$76.85 - $89.45 $331,454 - $385,797
4,313 Added 63.23%
11,134 $863,000
Q1 2022

Aug 08, 2022

SELL
$76.85 - $89.45 $845 - $983
-11 Reduced 0.16%
6,821 $528,000
Q4 2021

Jan 12, 2022

BUY
$74.57 - $87.19 $7,084 - $8,283
95 Added 1.41%
6,832 $590,000
Q3 2021

Oct 06, 2021

BUY
$73.77 - $83.61 $147,318 - $166,969
1,997 Added 42.13%
6,737 $545,000
Q2 2021

Jul 13, 2021

BUY
$80.5 - $88.01 $92,333 - $100,947
1,147 Added 31.92%
4,740 $380,000
Q1 2021

Apr 30, 2021

SELL
$76.38 - $86.03 $131,679 - $148,315
-1,724 Reduced 32.42%
3,593 $304,000
Q4 2020

Jan 25, 2021

SELL
$75.39 - $82.36 $23,672 - $25,861
-314 Reduced 5.58%
5,317 $421,000
Q3 2020

Oct 29, 2020

SELL
$78.33 - $90.73 $20,209 - $23,408
-258 Reduced 4.38%
5,631 $454,000
Q2 2020

Aug 05, 2020

SELL
$78.66 - $94.14 $67,647 - $80,960
-860 Reduced 12.74%
5,889 $497,000
Q1 2020

May 12, 2020

BUY
$71.57 - $93.3 $31,132 - $40,585
435 Added 6.89%
6,749 $541,000
Q4 2019

Jan 17, 2020

SELL
$76.7 - $88.45 $111,291 - $128,340
-1,451 Reduced 18.69%
6,314 $529,000
Q3 2019

Nov 07, 2019

BUY
$81.4 - $89.78 $583,719 - $643,812
7,171 Added 1207.24%
7,765 $669,000
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $691,290 - $871,724
-10,721 Reduced 94.75%
594 $50,000
Q4 2018

Jan 23, 2019

SELL
$61.45 - $77.8 $3,564 - $4,512
-58 Reduced 0.51%
11,315 $744,000
Q3 2018

Oct 25, 2018

BUY
$70.71 - $77.75 $187,735 - $206,426
2,655 Added 30.45%
11,373 $0
Q2 2018

Aug 07, 2018

BUY
$63.43 - $75.41 $95,398 - $113,416
1,504 Added 20.85%
8,718 $0
Q1 2018

Jun 03, 2019

SELL
$62.56 - $72.26 $63,498 - $73,343
-1,015 Reduced 12.33%
7,214 $466,000
Q1 2018

May 09, 2018

BUY
$62.56 - $72.26 $63,498 - $73,343
1,015 Added 14.07%
8,229 $0
Q4 2017

Jan 24, 2018

SELL
$61.45 - $66.05 $612,103 - $657,924
-9,961 Reduced 58.0%
7,214 $0
Q3 2017

Oct 30, 2017

BUY
$59.5 - $64.61 $3,213 - $3,488
54 Added 0.32%
17,175 $1.08 Million
Q2 2017

Jun 03, 2019

SELL
N/A
-1,135 Reduced 6.22%
17,121 $1.04 Million
Q1 2017

Jun 03, 2019

BUY
N/A
1,343 Added 7.94%
18,256 $947,000
Q4 2016

Jun 03, 2019

SELL
N/A
-1,162 Reduced 6.43%
16,913 $750,000
Q2 2016

Jun 03, 2019

BUY
N/A
17,481 Added 2942.93%
18,075 $817,000
Q1 2016

Jun 03, 2019

BUY
N/A
594
594 $50,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.